Clinical Trials Browser

Phase 2 × Transplant-Related Hematologic Malignancy × sargramostim × Clear all

NCT04237623 2025-10-30

GM-CSF With Post-Transplant Cyclophosphamide

Phase 2 Recruiting

Transplant-Related Hematologic Malignancy